CL-64825

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCL-64825
Drug Alias NameCL-64825
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial nucleic acid synthesis inhibitorsDNA synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLederle Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLederle Laboratories
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A